This form should not be used to request early access to quizartinib. Click here to go back to instructions for quizartinib.
Please answer each question, acknowledge the certification, and hit the submit button. PLEASE DO NOT INCLUDE ANY PATIENT MEDICAL RECORDS WITH THIS APPLICATION.
Daiichi Sankyo Europe GmbH
81379 Munich – Germany
Phone: + 49 89 78080
Daiichi Sankyo Co., Ltd - Global